Santhera Pharmaceuticals Holding AG Logo

Santhera Pharmaceuticals Holding AG

ISIN

CH0027148649

Ticker

SANN

Sector

Health Care

Sub-Industry

Pharmaceuticals

Country

Switzerland

Year Founded

2004

About Santhera Pharmaceuticals Holding AG

Company Description

We are focusing on the development of treatments for neuromuscular and pulmonary diseases that currently lack treatment options, such as Duchenne muscular dystrophy (DMD) and cystic fibrosis (CF).
We have dedicated more than a decade to researching potential treatments in our ongoing mission to make effective medicines available for these often overlooked, life-altering diseases. We are passionate about improving patients’ quality of life and our vision is to be a leader in providing treatments for rare diseases in these areas with high unmet medical needs.

Headcount

91

Served Area

Worldwide

Headquarters

Hohenrainstrasse 24
4133, Pratteln
Switzerland

Insider Trades

Date Trading entity / Person Association Trade type Volume
11.01.2022 None Non-Executive member Buy CHF 42,600.00
10.01.2022 None Executive member Buy CHF 14,420.00
05.01.2022 None Executive member Buy CHF 37,000.00

Capital Markets Information

ISIN

CH0027148649

LEI

54930035HAOFTTQH0U85

Sub-Industry

Pharmaceuticals

Listed Stock Exchange

SIX Swiss Exchange

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.